欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0293/003
药品名称
NEODUPLAMOX
活性成分
amoxicillin 400.0 mg
clavulanic acid 57.0 mg
剂型
Powder for oral suspension
上市许可持有人
VALEAS Spa, Via Vallisneri, 10 20133 Milano Italy
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
许可日期
2013/03/27
最近更新日期
2023/12/07
药物ATC编码
J01CR02 amoxicillin and beta-lactamase inhibitor
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
Neoduplamox_common_combined_clean
Date of last change:2023/11/23
Final SPC
|
Neoduplamox-tacked
Date of last change:2021/01/30
Final Product Information
|
VC2.2019. 578 common-combined-tracked-rev-30.7.20 (1) condivisi_ da pubblicare
Date of last change:2020/10/27
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase